This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vivien, E.
Right arrow Articles by Royer, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vivien, E.
Right arrow Articles by Royer, M.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, April 2007, p. 1549-1552, Vol. 51, No. 4
0066-4804/07/$08.00+0     doi:10.1128/AAC.01450-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Heterologous Production of Albicidin: a Promising Approach to Overproducing and Characterizing This Potent Inhibitor of DNA Gyrase{triangledown}

Eric Vivien,1 Delphine Pitorre,1 Stéphane Cociancich,1 Isabelle Pieretti,1 Dean W. Gabriel,2 Philippe C. Rott,1 and Monique Royer1*

Centre de Coopération Internationale en Recherche Agronomique pour le Développement, UMR Agro.M-Cirad-Inra BGPI, Campus International de Baillarguet, TA 41/K, 34398 Montpellier Cedex 5, France,1 Department of Plant Pathology, University of Florida, Gainesville, Florida 326112

Received 20 November 2006/ Returned for modification 18 December 2006/ Accepted 27 December 2006


arrow
ABSTRACT
 
The phytotoxin and polyketide antibiotic albicidin produced by Xanthomonas albilineans is a highly potent DNA gyrase inhibitor. Low yields of albicidin production have slowed studies of its chemical structure. Heterologous expression of albicidin biosynthetic genes in X. axonopodis pv. vesicatoria resulted in a sixfold increase in albicidin production, offering promising strategies for engineering overproduction.


arrow
TEXT
 
Albicidin is produced by Xanthomonas albilineans which is a slow-growing bacterium and the causal agent of sugarcane leaf scald (13). Albicidin is involved in the pathogenicity of X. albilineans and inhibits the replication of chloroplastic DNA (6, 7). Albicidin also inhibits DNA replication in Escherichia coli at nanomolar concentrations (4), whereas mammalian cells are unaffected at 8 µg/ml (3). A recent study showed that albicidin targets DNA gyrase with features of inhibition that differ from those of other known antibiotics (11). Albicidin is synthesized by a unique hybrid polyketide synthase-nonribosomal peptide synthetase (PKS-NRPS) pathway that does not resemble any other pathway described to date. Three genomic regions (XALB1, XALB2, and XALB3) involved in albicidin biosynthesis were cloned and sequenced (12, 14, 15, 17). XALB1 contains the majority of albicidin biosynthetic genes in a cluster of 20 open reading frames (ORFs) (albI to albXX). ORFs albI, albIV, and albIX encode three large PKSs and NRPSs, whereas the other ORFs are resistance, modifying, and regulatory genes. XALB2 and XALB3 each contain a single biosynthetic gene, albXXI and albXXII, whose products are, respectively, a phosphopantetheinyl transferase and the heat shock protein HtpG. The antibiotic activity of albicidin against a wide range of gram-positive and gram-negative pathogenic bacteria (Enterobacter aerogenes, E. coli, Haemophilus influenzae, Klebsiella pneumoniae, Shigella sonnei, and Staphylococcus aureus) is of interest for the development of new antibacterial drugs (4, 5). Low yields of albicidin production in slow-growing X. albilineans have slowed studies of its chemical structure and potential therapeutic applications. A heterologous system for albicidin overproduction is therefore highly desirable (i) to increase the levels of expression of the biosynthetic enzymes, (ii) to obtain large quantities of albicidin, and (iii) to characterize albicidin through nuclear magnetic resonance and mass spectrometry analyses. We report here the construction of a two-plasmid expression system harboring the complete albicidin biosynthetic gene set; its transfer into a fast-growing heterologous host, X. axonopodis pv. vesicatoria; and the subsequent production of albicidin.

Two wide-host-range plasmids derived from IncW vector pUFR043 (10) and IncP vector pLAFR3 (16) were used for the transfer of the complete albicidin biosynthetic machinery. The previously described IncW plasmid pALB571 (12, 14) was used to transfer albI to albIX (the insert corresponds to nucleotides 19001 to 55839 of accession no. AJ586576). Plasmid pLAFRK7 was constructed by ligating together into pLAFR3 the three following genomic DNA fragments: (i) nucleotides 5896 to 19216 of accession no. AJ586576 (harboring albX to albXX), (ii) nucleotides 1 to 2986 of accession no. AJ586577 (harboring albXXI), and (iii) nucleotides 5510 to 8119 of accession no. AM039979 (harboring albXXII), respectively. Both plasmids were transferred by triparental mating into X. axonopodis pv. vesicatoria strain Xcv 91-118 (1), and bioassays for albicidin production were performed with exconjugants. Triparental matings were performed as described previously (12) except that exconjugants were selected on SPA medium (2% sucrose, 0.5% peptone, 1.5% agar) supplemented with kanamycin at 50 µg/ml (for the transfer of pALB571) and tetracycline at 12 µg/ml (for the transfer of pLAFRK7). Bioassays for albicidin production were performed as described previously (12) except that (i) exconjugants were spotted onto SPA medium supplemented with gentamicin at 3 µg/ml, tetracycline at 12 µg/ml, and morpholinepropanesulfonic acid (MOPS) buffer and (ii) the plates were overlaid with a suspension of E. coli DH5{alpha} harboring pUFR043 and pLAFR3 empty plasmids that confer resistance to gentamicin and tetracycline, respectively. All exconjugants harboring plasmids pALB571 and pLAFRK7 produced an antibiotic that inhibited the growth of E. coli DH5{alpha}. No antibiotic production was observed with control exconjugants harboring either pALB571 or pLAFRK7 and one empty vector (and therefore missing some albicidin biosynthetic genes). These data demonstrated that transfer of the complete albicidin biosynthetic machinery into X. axonopodis pv. vesicatoria led to the heterologous production of an antibiotic that was named albicidinves. The exconjugant yielding the largest DH5{alpha} growth inhibition zone was designated Xves-alb and was used for further analyses.

Cross-resistance between albicidin and albicidinves was characterized by bioassays with agar cultures of Xves-alb using E. coli strains expressing a wide range of albicidin resistance determinants. Strain DH5{alpha}Albr (a spontaneous albicidin-resistant DH5{alpha} derivative [12]) and strain DH5{alpha}AlbD (expressing the albicidin-detoxifying gene albD [19]) were completely resistant to albicidinves. Strains harboring albXIV (an albicidin efflux pump gene conferring albicidin resistance in E. coli [8]), albXIX (an albicidin qnr gene conferring resistance in E. coli [11]), or sbmC (a gyrase inhibitor resistance gene [2]) were also resistant to albicidinves but to a lesser extent. This resistance pattern was identical to the one observed with X. albilineans cultures or with albicidin semipurified from X. albilineans. In addition, several E. coli DH5{alpha} clones that spontaneously grew within the growth inhibition zone of Xves-alb were resistant to albicidin, confirming the cross-resistance between the two antibiotics. Albicidin and albicidinves appeared, therefore, to display the same biological activities.

The growth of Xves-alb and the production of albicidinves were monitored in several rich liquid media supplemented with gentamicin at 3 µg/ml and tetracycline at 12 µg/ml: NYG (0.3% yeast extract, 0.5% peptone, 2% glycerol), TY (0.3% yeast extract, 0.5% tryptone, 5 mM CaCl2), and YM (0.3% yeast extract, 0.3% malt extract, 1% peptone). Maximum albicidinves activity was obtained in early stationary phase from shaken cultures grown at 28°C, and the best results were obtained in NYG with an albicidinves titer of 970 µg/liter. Albicidin was quantified with a bioassay, using the following formula developed by Zhang et al. (20): free albicidin (ng/ml) = 4.576 e(0.315 x inhibition zone diameter in mm). This titer was six times higher than the titer of albicidin produced by X. albilineans in the optimized SP8 medium (0.5% sucrose, 0.23% peptone, 0.1% yeast extract, 3 mM K2HPO4, 1 mM MgSO4; pH 7). In order to minimize the presence of catabolites in the supernatant and to facilitate the subsequent purification of albicidinves, we investigated growth of Xves-alb and the production of albicidinves in minimal media without gentamicin and tetracycline. We tested the XVM2 medium [20 mM NaCl, 10 mM (NH4)2SO4, 5 mM MgSO4, 1 mM CaCl2, 0.16 mM KH2PO4, 0.32 mM K2HPO4, 0.01 mM FeSO4, 0.03% Casamino Acids; pH 6.7] (18) supplemented with a single carbon source (mannitol, glucose, fructose, sucrose, or glycerol). The best albicidinves titer (200 µg/liter) was obtained in XVM2 supplemented with 2% glycerol. A decrease of albicidin production in minimum media was also observed in X. albilineans (4).

The chromatographic behaviors of albicidin and albicidinves were then compared by thin-layer chromatography (TLC). Albicidinves was analyzed from cultures of Xves-alb grown to early stationary phase (48 h) in 5 liters of XVM2 medium supplemented with 2% glycerol and without any antibiotic, and albicidin was analyzed from cultures of X. albilineans strain Xa23R1 to stationary phase (96 h) in 5 liters of SP8 medium. Supernatants from bacterial cultures were loaded onto Amberlite XAD-7 (Sigma) resin column, washed, and eluted with methanol. The fractions exhibiting an antibiotic activity at a 1,000-fold dilution were pooled and vacuum dried to a final volume of 0.5 ml. Then, 2-µl samples were separated by TLC chromatography with silica gel 60F254 TLC aluminum sheets (20 by 20 cm; Merck, Darmstadt, Germany) using methanol as the mobile phase. Subsequently, strips of the TLC plate were placed for 2 h at room temperature on the surface of a top agar layer containing an E. coli indicator strain. Inhibition zones, observed after overnight incubation at 37°C, documented the positions of antibiotics separated by TLC. Two indicator strains sensitive to albicidin and two indicator strains resistant to albicidin were tested (Fig. 1). All indicator strains harbored pUFR043 and pLAFR3 empty plasmids that confer resistance to gentamicin and tetracycline, respectively (antibiotics that were present in the inoculum of Xves-alb). A single growth inhibition zone was observed at the same position with the two DH5{alpha} derivative sensitive indicator strains for the samples prepared from X. axonopodis pv. vesicatoria strain Xves-alb and from X. albilineans strain Xa23R1. The absence and a significant intensity reduction of inhibition zones with resistant strains DH5{alpha}Albr and DH5{alpha}AlbD, respectively, confirmed that the antibiotics separated by TLC chromatography were albicidin.


Figure 1
View larger version (142K):
[in this window]
[in a new window]

  		FIG. 1. Analysis of antibiotics separated by TLC from supernatants of cultures of strains X. albilineans Xa23R1 and X. axonopodis pv. vesicatoria Xves-alb. Samples prepared from bacterial supernatants were subjected to TLC, and TLC strips were laid on top agar layers containing different E. coli indicator strains: DH5{alpha} (lane a); DH5{alpha}Albr (lane b), a spontaneous albicidin-resistant DH5{alpha} derivative described previously (12); DH5{alpha} transformed with the pGEX-4T-3 empty vector (Pharmacia) (lane c); and DH5{alpha} transformed with pGEXAlbD (DH5{alpha}AlbD) and expressing albD, an albicidin-detoxifying gene conferring albicidin resistance in E. coli (19) (lane d). All E. coli indicator strains were transformed with pUFR043 and pLAFR3 empty vectors to confer resistance to gentamicin and tetracycline, respectively. The initial positions of the samples on the chromatograms are indicated by "x".

In conclusion, we describe here the heterologous production of albicidin in the fast-growing bacterium X. axonopodis pv. vesicatoria, with production yields sixfold higher than those observed with X. albilineans. In addition to growing faster than X. albilineans, this heterologous production system has the substantial advantage of being more easily modifiable by genetic engineering because albicidin biosynthetic genes are cloned in plasmids. The following modifications are promising for improving the production yield of albicidin in this heterologous system: (i) the replacement of native promoters by constitutive promoters in order to suppress negative transcriptional control of albicidin production; (ii) the replacement of TTG codons for the initiation of translation by ATG codons in order to suppress any negative posttranscriptional control due to the presence of these TTG codons; (iii) the overexpression of the albicidin efflux pump (and/or the Qnr albicidin resistance protein) in order to facilitate the excretion of the antibiotic into the culture medium and potentially increase resistance; and (iv) the overexpression of the biosynthetic enzymes functioning in trans in order to improve the efficacy of the PKS-NRPS system. This latter approach was successfully used to improve the production of leinamycin by Streptomyces atroolivaceus (9). The present study is a first significant step in the overproduction of albicidin that will be necessary to purify large quantities of albicidin and to characterize this potent inhibitor of DNA gyrase that differs from other known antibiotics.


arrow
ACKNOWLEDGMENTS
 
We thank Sandrine Duplan for technical support. We thank Felipe Moreno for supplying the SbmC-producing pMR100 strain and Lian Hui Zhang for supplying the AlbD-producing E. coli strain.

E.V. was supported by a fellowship from the Direction Scientifique du CIRAD.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Centre de Coopération Internationale en Recherche Agronomique pour le Développement, UMR Agro.M-Cirad-Inra BGPI, Campus International de Baillarguet, TA 41/K, 34398 Montpellier Cedex 5, France. Phone: (33) 4 99 62 48 44. Fax: (33) 4 99 62 48 08. E-mail: monique.royer{at}cirad.fr Back

{triangledown} Published ahead of print on 12 January 2007. Back


arrow
REFERENCES
 
    1
  1. Astua-Monge, G., G. V. Minsavage, R. E. Stall, M. J. Davis, U. Bonas, and J. B. Jones. 2000. Resistance of tomato and pepper to T3 strains of Xanthomonas campestris pv. vesicatoria is specified by a plant-inducible avirulence gene. Mol. Plant-Microbe Interact. 13:911-921.[Medline]
    2. 2
  2. Baquero, M. R., M. Bouzon, J. Varea, and F. Moreno. 1995. SbmC, a stationary-phase induced SOS Escherichia coli gene, whose product protects cells from the DNA replication inhibitor microcin B17. Mol. Microbiol. 18:301-311.[Medline]
    3. 3
  3. Birch, R. G. 1983. Phytotoxin production by Xanthomonas albilineans, the sugarcane leaf scald pathogen. Ph.D. thesis. University of Hawaii, Honolulu.
    4. 4
  4. Birch, R. G., and S. S. Patil. 1985. Preliminary characterization of an antibiotic produced by Xanthomonas albilineans which inhibits DNA synthesis in Escherichia coli. J. Gen. Microbiol. 131:1069-1075.[Abstract/Free Full Text]
    5. 5
  5. Birch, R. G., and S. S. Patil. June 1985. Antibiotic and process for the production thereof. U.S. patent 4,525,354.
    6. 6
  6. Birch, R. G., and S. S. Patil. 1987. Correlation between albicidin production and chlorosis induction by Xanthomonas albilineans, the sugarcane leaf scald pathogen. Physiol. Mol. Plant Pathol. 30:199-206.
    7. 7
  7. Birch, R. G., and S. S. Patil. 1987. Evidence that an albicidin-like phytotoxin induces chlorosis in sugarcane leaf scald disease by blocking plastid DNA replication. Physiol. Mol. Plant Pathol. 30:207-214.
    8. 8
  8. Bostock, J. M., G. Huang, S. M. Hashimi, L. Zhang, and R. G. Birch. 2006. A DHA14 drug efflux gene from Xanthomonas albilineans confers high-level albicidin antibiotic resistance in Escherichia coli. J. Appl. Microbiol. 101:151-160.[CrossRef][Medline]
    9. 9
  9. Cheng, Y. Q., G. L. Tang, and B. Shen. 2003. Type I polyketide synthase requiring a discrete acyltransferase for polyketide biosynthesis. Proc. Natl. Acad. Sci. USA 100:3149-3154.[Abstract/Free Full Text]
    10. 10
  10. De Feyter, R., and D. W. Gabriel. 1991. Use of cloned DNA methylase genes to increase the frequency of transfer of foreign genes into Xanthomonas campestris pv. malvacearum. J. Bacteriol. 173:6421-6427.[Abstract/Free Full Text]
    11. 11
  11. Hashimi, S. M., M. K. Wall, A. B. Smith, A. Maxwell, and R. G. Birch. 2007. The phytotoxin albicidin is a novel inhibitor of DNA gyrase. Antimicrob. Agents Chemother. 51:181-187.[Abstract/Free Full Text]
    12. 12
  12. Rott, P. C., L. Costet, M. J. Davis, R. Frutos, and D. W. Gabriel. 1996. At least two separate gene clusters are involved in albicidin production by Xanthomonas albilineans. J. Bacteriol. 178:4590-4596.[Abstract/Free Full Text]
    13. 13
  13. Rott, P., and M. J. Davis. 2000. Leaf scald, p. 38-44. In P. Rott, R. A. Bailey, J. C. Comstock, B. J. Croft, and A. S. Saumtally (ed.), A guide to sugarcane diseases. La Librairie du Cirad, Montpellier, France.
    14. 14
  14. Royer, M., L. Costet, E. Vivien, M. Bes, A. Cousin, A. Damais, I. Pieretti, A. Savin, S. Megessier, M. Viard, R. Frutos, D. W. Gabriel, and P. C. Rott. 2004. Albicidin pathotoxin produced by Xanthomonas albilineans is encoded by three large PKS and NRPS genes present in a gene cluster containing also several putative modifying, regulatory, and resistance genes. Mol. Plant-Microbe Interact. 17:414-427.[Medline]
    15. 15
  15. Royer, M., D. W. Gabriel, R. Frutos, and P. Rott. November 2006. Complete biosynthetic gene set for synthesis of polyketide antibiotics, including the albicidin family, resistance genes, and uses thereof. U.S. patent 0269988-A1.
    16. 16
  16. Staskawicz, B., D. Dahlbeck, N. Keen, and C. Napoli. 1987. Molecular characterization of cloned avirulence genes from race 0 and race 1 of Pseudomonas syringae pv. glycinea. J. Bacteriol. 169:5789-5794.[Abstract/Free Full Text]
    17. 17
  17. Vivien, E., S. Megessier, I. Pieretti, S. Cociancich, R. Frutos, D. W. Gabriel, P. C. Rott, and M. Royer. 2005. Xanthomonas albilineans HtpG is required for biosynthesis of the antibiotic and phytotoxin albicidin. FEMS Microbiol. Lett. 251:81-89.[CrossRef][Medline]
    18. 18
  18. Wengelnik, K., C. Marie, M. Russel, and U. Bonas. 1996. Expression and localization of HrpA1, a protein of Xanthomonas campestris pv. vesicatoria essential for pathogenicity and induction of the hypersensitive reaction. J. Bacteriol. 178:1061-1069.[Abstract/Free Full Text]
    19. 19
  19. Zhang, L., and R. G. Birch. 1997. The gene for albicidin detoxification from Pantoea dispersa encodes an esterase and attenuates pathogenicity of Xanthomonas albilineans to sugarcane. Proc. Natl. Acad. Sci. USA 94:9984-9989.[Abstract/Free Full Text]
    20. 20
  20. Zhang, L., J. Xu, and R. G. Birch. 1998. Factors affecting biosynthesis by Xanthomonas albilineans of albicidin antibiotics and phytotoxins. J. Appl. Microbiol. 85:1023-1028.[Medline]

Antimicrobial Agents and Chemotherapy, April 2007, p. 1549-1552, Vol. 51, No. 4
0066-4804/07/$08.00+0     doi:10.1128/AAC.01450-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Renier, A., Vivien, E., Cociancich, S., Letourmy, P., Perrier, X., Rott, P. C., Royer, M. (2007). Substrate Specificity-Conferring Regions of the Nonribosomal Peptide Synthetase Adenylation Domains Involved in Albicidin Pathotoxin Biosynthesis Are Highly Conserved within the Species Xanthomonas albilineans. Appl. Environ. Microbiol. 73: 5523-5530 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vivien, E.
Right arrow Articles by Royer, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vivien, E.
Right arrow Articles by Royer, M.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»